| Trial ID: | L0730 |
| Source ID: | IRCT20150706023083N2
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Comparison of the theraputic effect of pioglitazone and metformin on ultrasound scoring and liver enzymez in potients with non alcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non alcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified;K76.0
|
| Interventions: |
Intervention 1: Intervention group: the first group received pioglitazone 30 mg for 6 months. Intervention 2: Intervention group: second group received metformin 1 gr and VitE 800 for 6 months.
|
| Outcome Measures: |
Serum Spartate Aminotransferase Level. Timepoint: On arrival and after intervention. Method of measurement: Laboratory methods with Kits.;Grade sonography. Timepoint: On arrival and after intervention. Method of measurement: Ultrasound machine.;Serum levels of alanine amino transferase. Timepoint: On arrival and after intervention. Method of measurement: Laboratory methods with Kits.nan
|
| Sponsor/Collaborators: |
Tabriz University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years65 years
|
| Phases: |
Phase 3
|
| Enrollment: |
68
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Randomization description: Randomization tool: such as random number table, sealed envelope, statistical software .
|
| Start Date: |
23/09/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
5 November 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/39566
|
